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Introduction: It is widely known that a number of chronic neurodegenerative disorders 
are related with dysfunctional mitochondria. Although it has been proposed that 
Acetyl-L-Carnitine (ALC) confers neuroprotection through mitochondria viability 
improvement, little is known concerning the molecular mechanisms involved. We 
propose to characterize the action of ALC in mitochondria bioenergetics and functional 
integrity.  
Material and Methods: The rat pheochromocytoma cell line (PC12) is often used as an 
in vitro model to study the dopaminergic function. Here, PC12 cells were exposed to 
the toxic effects of methamphetamine (METH 1 and 100 µM) and pretreated with 
increasing doses of ALC (0.01, 0.1 and 1.0 mM). After 24 or 72h of incubation, 
mitochondrial membrane integrity and mitochondrial mass were assessed by using, 
respectively, Mitotracker CMXRos (2 μM) and Mitotracker Green (800 nM) by flow 
cytometry. Efficiency of glucose utilization was also assessed by incubating the cells 
with 37 kBq/mL of 18F-FDG (2-deoxy-2-[18F]fluoro-D-glucose) in a low glucose serum-
free medium for 60 minutes. The total protein content was assessed. 
Results: Although ALC by itself did not improve mitochondrial function, ALC (0.01mM 
and 0.1mM) was effective in preventing the decrease induced by a 72h exposure to 
METH (p<0.001). Regarding mitochondrial mass, ALC in higher doses seems to induce a 
transitory increase of mitochondria mass (p<0.05). Furthermore, while a prolonged 
exposure to high levels of METH decreased mitochondria mass (p<0.001) pretreatment 
with ALC prevented this effect. Concerning the glucose metabolism, we observed an 
 increment on glucose uptake 24h after treating the cells with ALC 0.01 mM (p<0.05). 
This was even more pronounced when cells were also exposed to METH 100 µM 
(p<0.01). At 72h, cells treated with ALC 1.0 mM presented a significant increased 
glucose uptake in all tested conditions. While this may partially reflect increased 
energy use, it may also be caused by altered membrane permeability. Importantly, ALC 
dosing seems to be highly relevant in this process. 
Conclusion: Results indicate that ALC improves and protects mitochondrial functional 
in a dose and time-dependent manner. While lower concentrations seem to be 
beneficial, higher concentration may interfere with cell bioenergetics in a negative 
way. 
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